Katsumasa Sato: "Prospects for development of new anti-microbials for clinical control of tuberculosis. In vitro antimicrobial activities of quinolones, refamycins and macrolides against Mycobacterium tuberculosis and M.avium complex : Attempt to establis
Katsumasa Sato: "Prospects for development of new anti-microbials for clinical control of tuberculosis. In vitro antimicrobial activities of quinolones, refamycins and macrolides against Mycobacterium tuberculosis and M.avium complex : Attempt to establis
复制标题
Katsumasa Sato：“开发用于临床控制结核病的新型抗微生物药物的前景。喹诺酮类、利福霉素和大环内酯类药物对结核分枝杆菌和鸟分枝杆菌复合体的体外抗菌活性：尝试建立
DOI：
--
复制
发表时间：
--
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
